1310383-50-6

(6-(3-Methylpiperidin-1-yl)pyridin-2-yl)boronic acid

1H-Pyrazole, 3,5-diphenyl-1-(3-pyridinylcarbonyl)-

1H-Indazole,5-chloro-3-[5-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-1H-benzimidazol-2-yl]-, rel-

1H-Pyrazole, 3-[3,4-bis(dodecyloxy)phenyl]-5-methyl-

1H-Pyrazole, 3,5-dimethyl-4-phenyl-

1H-Pyrazole-4-propanoic acid, 3-propyl-, ethyl ester

1H-Pyrazole, 4,5-dihydro-1,3-diphenyl-4,5-bis(phenylsulfonyl)-

1H-Indazole-3-carboxamide, 5-(acetylamino)-N-phenyl-

1H-Indazole-3-carboxaldehyde, 6-nitro-1-phenyl-4-[(phenylmethyl)thio]-

1H-Pyrazole-4-carboxylic acid,1-[2-[(tetrahydro-2H-pyran-2-yl)oxy]ethyl]-, ethyl ester

1H-Indazole, 7-chloro-3-[5-(4-morpholinyl)-1H-benzimidazol-2-yl]-

1H-Indazole, 6-nitro-3-[5-(1-piperazinyl)-1H-benzimidazol-2-yl]-

4-methyl-n'-(2-pyridinylmethylene)benzenesulfonohydrazide

1H-Indazole-3-carboxamide, 5-chloro-N-phenyl-

1H-Indazole,4-methoxy-5-(5-methyl-1,3,4-oxadiazol-2-yl)-3-[(1E)-2-(3-pyridinyl)ethenyl]-

1H-Indazole,5-fluoro-3-[4-fluoro-5-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-

1H-Pyrazole-4-carboxylic acid,1-methyl-3-[4-nitro-2-(trifluoromethyl)phenoxy]-, ethyl ester

1H-Pyrazole, 5-[5-(2-chlorophenyl)-2-furanyl]-4,5-dihydro-3-phenyl-

1H-Pyrazole, 4-(4-chlorophenyl)-1-phenyl-

1H-Pyrazole-4-propanoic acid,1-methyl-3-[3-[3-(1-methylethyl)-1-[5-(trifluoromethyl)-2-pyridinyl]-1H-pyrazol-4-yl]propoxy]-

7H-Pyrrolo[3,2-f]quinazoline-1,3-diamine, 7-(2-benzothiazolyl)-

Oxacyclotetradec-11-ene-2,4,10-trione,14-ethyl-6-hydroxy-5,7,9,11,13-pentamethyl-,(5R,6S,7S,9R,11E,13R,14R)-

1H-Pyrazole, 3-[4-(2-penten-4-ynyloxy)phenyl]-

1H-Indazole,1-acetyl-4,5-dihydro-4-(4-methoxyphenyl)-3-methyl-6-phenyl-

1H-Pyrazole, 4,5-dichloro-1-[2,4-dichloro-5-(1-methylethoxy)phenyl]-

1H-Pyrazole-4-carboxylic acid, 5-methyl-1-phenyl-, phenylmethyl ester

1H-Pyrazole-4-propanoic acid, 5-(4-chlorophenyl)-1-methyl-, ethyl ester

1H-Indazole,5-(phenylmethoxy)-3-[5-(1-piperazinyl)-1H-benzimidazol-2-yl]-

7H-Pyrrolo[2,3-g]pteridin-7-one,8-acetyl-9-ethyl-5,5a,6,8,8a,9-hexahydro-4-methyl-2-(4-morpholinyl)-6-(2-pyridinyl)-

9,10,10a,11a-tetrahydrotriphenyleno[1,2-b]thiirene

1H-Indazole,3-(4-fluorophenyl)-5-(phenylethynyl)-1-(tetrahydro-2H-pyran-2-yl)-

(4-methoxy-3-methylpyridin-2-yl)methanamine

1H-Indazole,3-(4-fluorophenyl)-5-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-

1H-Pyrazole, 4-(1,3-benzodioxol-5-yl)-3-methyl-

BRIAREOLIDE I

1H-Pyrazole, 5-bromo-1-[4-chloro-2-fluoro-5-(1-methylethoxy)phenyl]-

1H-Indazole, 7-methyl-3-[5-(4-morpholinyl)-1H-benzimidazol-2-yl]-

1310383-50-6 msds

CAS No 1310383-50-6 supplier

CASNo 1310383-50-6 distributor

CAS # 1310383-50-6 manufacturer

CAS Number 1310383-50-6 safety

CAS RN 1310383-50-6 wholesale

2026-10-12 Find (6-(3-Methylpiperidin-1-yl)pyridin-2-yl)boronic acid,CAS No.1310383-50-6,Formula:C11H17BN2O2 in ChemToTech